E-LIB Suche - Ergebnisse für: Chiorean, E. G

1

Clinical Outcomes and Immunotoxicity in People with HIV (PW..:

Anderson, A.C. ; Menon, M. ; Cohen, S.A....
International Journal of Radiation Oncology*Biology*Physics. 117 (2023) 2 - p. e282-e283 , 2023

Link: https://doi.org/10.1016/..

2

Positron emission tomography (PET) as a predictive measure ..:

Ramanathan, R.K. ; Korn, R.L. ; Chiorean, E.G...
Annals of Oncology. 27 (2016) 8 - p. 1647-1648 , 2016

Link: https://doi.org/10.1093/..

3

CA19-9 decrease at 8 weeks as a predictor of overall surviv..:

Chiorean, E.G. ; Von Hoff, D.D. ; Reni, M....
Annals of Oncology. 27 (2016) 4 - p. 654-660 , 2016

Link: https://doi.org/10.1093/..

4

2346 Impact of nab-paclitaxel (nab-P) plus gemcitabine (G) ..:

Chiorean, E.G. ; Wan, Y. ; Whiting, S..
European Journal of Cancer. 51 (2015) - p. S450 , 2015

Link: https://doi.org/10.1016/..

5

617 Pharmacokinetic Study of Enzastaurin in Cancer Patients..:

Sarantopoulos, J. ; Chiorean, E.G. ; Stephenson, J....
European Journal of Cancer. 48 (2012) - p. 190 , 2012

Link: https://doi.org/10.1016/..

6

Phase I pharmacokinetic and pharmacodynamic study of the pa..:

Mahadevan, D. ; Chiorean, E.G. ; Harris, W.B....
European Journal of Cancer. 48 (2012) 18 - p. 3319-3327 , 2012

Link: https://doi.org/10.1016/..

7

A Phase I Study of the Pharmacokinetic and Safety Profiles ..:

Heath, E I ; Chiorean, E G ; Sweeney, C J...
Clinical Pharmacology & Therapeutics. 88 (2010) 6 - p. 818-823 , 2010

Link: https://doi.org/10.1038/..

8

1226 Multi-arm Phase IB study of TH-302 in combination with..:

Borad, M. ; Infante, J.R. ; Mita, A.C....
European Journal of Cancer Supplements. 7 (2009) 2 - p. 128 , 2009

Link: https://doi.org/10.1016/..

9

41 POSTER DCE-MRI endpoints reveal decreased tumor vascular..:

Serkova, N.J. ; Spratlin, J. ; Eckhardt, S.G....
European Journal of Cancer Supplements. 6 (2008) 12 - p. 16 , 2008

Link: https://doi.org/10.1016/..

10

412 POSTER A first-in-man phase I study of TH-302, a hypoxi..:

Weiss, G.J. ; Infante, J.R. ; Borad, M....
European Journal of Cancer Supplements. 6 (2008) 12 - p. 129-130 , 2008

Link: https://doi.org/10.1016/..

11

3523 POSTER Glufosfamide (GLU) plus gemcitabine (GEM) in pa..:

Chiorean, E. ; Dragovich, T. ; Hamm, J....
European Journal of Cancer Supplements. 5 (2007) 4 - p. 266 , 2007

Link: https://doi.org/10.1016/..

12

Evofosfamide for the treatment of human papillomavirus-nega..:

Jamieson, Stephen M.F. ; Tsai, Peter ; Kondratyev, Maria K....
JCI Insight. 8 (2023) 4 - p. , 2023

Link: https://doi.org/10.1172/..

13

KRAS Mutation Variants and Co-occurring PI3K Pathway Altera..:

Diehl, Adam C ; Hannan, Lindsay M ; Zhen, David B...
The Oncologist. 27 (2022) 12 - p. 1025-1033 , 2022

Link: https://doi.org/10.1093/..

14

Preemptive Versus Reactive Topical Clobetasol for Regorafen..:

Jatoi, Aminah ; Ou, Fang-Shu ; Ahn, Daniel H....
The Oncologist. 26 (2021) 7 - p. 610-618 , 2021

Link: https://doi.org/10.1002/..

15

Nomogram for Estimating Overall Survival in Patients with M..:

Goldstein D ; Von Hoff D. D ; Chiorean E. G...
info:eu-repo/semantics/altIdentifier/pmid/32541630. , 2020

Link: https://hdl.handle.net/2..